MV Capital Management’s Medifast MED Stock Holding History

MV Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-26	Closed	-$3K	–	362
2018 Q4	$3K	Sell	26 -70	-73%	-$12K	﹤0.01%	292
2018 Q3	$21K	Hold	96	–	–	0.01%	198
2018 Q2	$15K	Hold	96	–	–	﹤0.01%	223
2018 Q1	$9K	Hold	96	–	–	﹤0.01%	252
2017 Q4	$7K	Buy	+96	New	+$6.37K	﹤0.01%	281

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

HCM

Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

MV Capital Management's MED Position: Q1 2019 in Review

MV Capital Management sold out of Medifast (MED) in Q1 2019, closing a stake of 26 shares — an estimated $3K sold.

MV Capital Management first reported a position in MED in Q4 2017 and held it in 5 quarters. The position peaked at $21K in Q3 2018. 246 funds tracked by Wall St. Rank hold MED as of Q1 2019.

MV Capital Management reported no remaining Medifast position as of Q1 2019 after selling out during the quarter.
MV Capital Management sold 26 Medifast shares in Q1 2019, an estimated $3K.
MV Capital Management first reported a position in Medifast in Q4 2017 and held it in 5 quarters.
MV Capital Management's Medifast position peaked at $21K in Q3 2018.
246 funds tracked by Wall St. Rank held Medifast as of Q1 2019.

Based on MV Capital Management's 13F filing for Q1 2019, filed 2 May 2019.